Camostat
| CAS No. | 59721-28-7 |
|---|---|
| MDL No. | N/A |
| MF | C20H22N4O5 |
| MW | 398.40 |
| InChI Key | XASIMHXSUQUHLV-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Camostat is a benzoate ester formed by the condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of human transmembrane protease serine 2 (TMPRSS2), with its mesylate salt being investigated for use in COVID-19 treatment. Camostat functions as an anticoronaviral, serine protease inhibitor, antifibrinolytic, anti-inflammatory, antiviral, antihypertensive, and antineoplastic agent. It is a tertiary carboxamide, carboxylic ester, diester, guanidine, and benzoate ester, and is functionally related to 4-guanidinobenzoic acid. It is the conjugate base of camostat(1+).
| CAS No. | 59721-28-7 |
|---|---|
| Product Name | Camostat |
Associated Conditions
severe acute respiratory syndrome·COVID-19·Protein-losing enteropathy
* The information provided here is compiled from public sources and is for reference only.
